These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 1599815)

  • 1. Mechanisms of tissue destruction and cellular activation in rheumatoid arthritis.
    Firestein GS
    Curr Opin Rheumatol; 1992 Jun; 4(3):348-54. PubMed ID: 1599815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biology of cartilage and bone destruction.
    Müller-Ladner U; Gay RE; Gay S
    Curr Opin Rheumatol; 1998 May; 10(3):212-9. PubMed ID: 9608324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment.
    van Kuijk AW; Reinders-Blankert P; Smeets TJ; Dijkmans BA; Tak PP
    Ann Rheum Dis; 2006 Dec; 65(12):1551-7. PubMed ID: 16728461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines and oncogenes in cellular interactions of rheumatoid arthritis.
    Keyszer GM; Heer AH; Gay S
    Stem Cells; 1994 Jan; 12(1):75-86. PubMed ID: 8142924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogene activation in rheumatoid synovium.
    Trabandt A; Gay RE; Gay S
    APMIS; 1992 Oct; 100(10):861-75. PubMed ID: 1445692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis].
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Kita K
    Pol Merkur Lekarski; 2006 Feb; 20(116):228-31. PubMed ID: 16708647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
    Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
    Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiology of rheumatoid arthritis].
    Morović-Vergles J
    Reumatizam; 2003; 50(2):15-7. PubMed ID: 15098367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of mesenchymal cells in the pathophysiology of inflammatory arthritis.
    Meyer LH; Franssen L; Pap T
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):969-81. PubMed ID: 16980218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenesis and immunopathology of rheumatoid polyarthritis].
    Cantagrel A
    Rev Prat; 1997 Nov; 47(18):1992-7. PubMed ID: 9501615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers.
    Kraan MC; Reece RJ; Barg EC; Smeets TJ; Farnell J; Rosenburg R; Veale DJ; Breedveld FC; Emery P; Tak PP
    Arthritis Rheum; 2000 Aug; 43(8):1820-30. PubMed ID: 10943872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis.
    Magalhães R; Stiehl P; Morawietz L; Berek C; Krenn V
    Virchows Arch; 2002 Nov; 441(5):415-27. PubMed ID: 12447670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synovium as a privileged site in rheumatoid arthritis: cadherin-11 as a dominant player in synovial pathology.
    Kiener HP; Karonitsch T
    Best Pract Res Clin Rheumatol; 2011 Dec; 25(6):767-77. PubMed ID: 22265259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synovial activation in rheumatoid arthritis.
    Ospelt C; Neidhart M; Gay RE; Gay S
    Front Biosci; 2004 Sep; 9():2323-34. PubMed ID: 15353290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis.
    Smeets TJ; Dayer JM; Kraan MC; Versendaal J; Chicheportiche R; Breedveld FC; Tak PP
    Arthritis Rheum; 2000 Feb; 43(2):270-4. PubMed ID: 10693865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inflammation and joint destruction during rheumatoid polyarthritis: what relation?].
    Combe B
    Presse Med; 1998 Mar; 27(10):481-3. PubMed ID: 9767983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of immune system, apoptosis and angiogenesis in pathogenesis of rheumatoid arthritis and joint destruction, a systematic review.
    Dhaouadi T; Sfar I; Abelmoula L; Jendoubi-Ayed S; Aouadi H; Ben Abdellah T; Ayed K; Zouari R; Gorgi Y
    Tunis Med; 2007 Dec; 85(12):991-8. PubMed ID: 19170375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The matrix metalloproteinase RASI-1 is expressed in synovial blood vessels of a rheumatoid arthritis patient.
    Kolb C; Mauch S; Peter HH; Krawinkel U; Sedlacek R
    Immunol Lett; 1997 Jun; 57(1-3):83-8. PubMed ID: 9232430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of the joint disease of rheumatoid arthritis.
    Zvaifler NJ
    Am J Med; 1983 Dec; 75(6A):3-8. PubMed ID: 6362405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A4 (Mts1): is there any relation to the pathogenesis of rheumatoid arthritis?
    Senolt L; Grigorian M; Lukanidin E; Michel BA; Gay RE; Gay S; Pavelka K; Neidhart M
    Autoimmun Rev; 2006 Feb; 5(2):129-31. PubMed ID: 16431343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.